Imricor Medical Systems, Inc.

ASX:IMR Stock Report

Market Cap: AU$276.9m

Imricor Medical Systems Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:IMR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 May 24BuyAU$45,000Steven WedanIndividual100,000AU$0.45
07 May 24BuyAU$48,368Peter McGregorIndividual100,000AU$0.48
28 Feb 24BuyAU$35,222Peter McGregorIndividual78,271AU$0.45

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IMR?
Owner TypeNumber of SharesOwnership Percentage
Public Companies8,384,1503.1%
Private Companies15,899,0275.88%
Individual Insiders23,371,8848.65%
Institutions33,439,05212.4%
General Public189,081,65370%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 59.9%.

Top Shareholders

Top 18 shareholders own 30.02% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.87%
Hart Capital Partners, Asset Management Arm
15,860,303AU$16.3m0%100.0%
4.76%
Saville Capital Pty Ltd
12,850,001AU$13.2m0%55.96%
4.15%
Hr Global Investments Llc
11,204,996AU$11.5m0%no data
3.1%
Siemens Aktiengesellschaft
8,384,150AU$8.6m0%no data
2.42%
Warren Herreid
6,535,110AU$6.7m0%no data
2.31%
Mark Tibbles
6,230,913AU$6.4m0%no data
1.88%
Steven Wedan
5,083,586AU$5.2m0%no data
1.09%
KAHR Foundation., Endowment Arm
2,950,988AU$3.0m0%no data
0.66%
Wilson Asset Management (International) Pty Ltd.
1,777,760AU$1.8m0%0.03%
0.65%
Maclay Group Pty. Ltd.
1,761,113AU$1.8m0%no data
0.63%
Bauer Private Equity Fund Vi
1,696,555AU$1.7m0%no data
0.54%
Matthew Banfield
1,461,868AU$1.5m0%no data
0.48%
Ronald Berger
1,300,000AU$1.3m0%no data
0.48%
Jeffrey Ira
1,288,462AU$1.3m0%no data
0.46%
Stojanov Investment Pty Ltd
1,236,363AU$1.3m0%no data
0.32%
Peter McGregor
873,035AU$894.9k0%no data
0.13%
Anita Messal
353,164AU$362.0k0%no data
0.091%
Jeffrey Leighton
245,746AU$251.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 23:46
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Imricor Medical Systems, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Elyse ShapiroBell Potter
Sarah MannMA Moelis Australia Securities Pty Ltd
Scott PowerMorgans Financial Limited